President von der Leyen declared at the Global Health Summit in Rome on May 21, 2021, that “Team Europe” would share at least 100 million doses with poor and middle-income nations by the end of 2021, mostly through COVAX, our global vaccine partner.
By the end of 2021, Team is on track to surpass this initial goal, with 200 million doses of COVID-19 vaccinations expected to be distributed to the most vulnerable countries.
By the end of this year, Team Europe’s commitment of more than 200 million doses of COVID-19 vaccinations will have arrived in their destination countries, primarily through COVAX. COVAX has distributed 122 million pills to 136 countries to date.
In the meantime, Team Europe has established an initiative in Africa to improve vaccine manufacturing and access to medications and health technologies.
The programme, which is sponsored by €1 billion from the EU budget and European development financing institutions like the European Investment Bank (EIB), will help create the ideal conditions for local vaccine manufacture in Africa.
Team Europe decided on July 9 to fund the Institut Pasteur in Dakar’s large-scale vaccine production investment, as well as other support measures. Africa’s 99 per cent reliance on vaccine imports will be reduced by the new manufacturing factory, which will also boost the continent’s future pandemic resilience.
The European Union has been a leading force behind the Coronavirus Global Response and the establishment of the ACT-Accelerator, the world’s first facility for access to COVID-19 vaccinations, diagnostics, and therapies.
Because most low- and middle-income nations require time and resources to develop their own manufacturing capacities, vaccine sharing remains the most immediate and practical solution.
On May 21, 2021, President von der Leyen and Prime Minister Mario Draghi of Italy convened the Global Health Summit. This was the first G20 health summit, and it heralded the start of a new era in global health policy.
To make this pandemic the last pandemic, world leaders pledged to multilateralism, global health cooperation, and increased vaccine manufacturing capacity around the world.